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Background. Although the persistence of multilin-
eage microchimerism in recipients of long-surviving 
organ transplants implies engraftment of migratory 
pluripotent donor stem cells, the ultimate localization 
in the recipient of these cells has not been determined 
in any species. 
Methods. Progenitor cells were demonstrated in the 
bone marrow and nonparenchymalliver cells of naive 
rats and in Brown Norway (BN) recipients of Lewis 
(LEW) allografts by semiquantitative colony-forming 
unit in culture (CFU-C) assays. The LEW allografts of 
bone marrow cells (BMC) (2.5X108 ), orthotopic livers, 
or heterotopic hearts (abdominal site) were trans-
planted under a 2-week course of daily tacrolimus, 
with additional single doses on days 20 and 27. Donor 
CFU-C colonies were distinguished from recipient col-
onies in the allografts and recipient bone marrow with 
a donor-specific MHC class II monoclonal antibody. 
The proportions of donor and recipient.colonies were 
estimated from a standard curve created by LEW and 
BN bone marrow mixtures of known concentrations. 
Results. After the BMC infusions, 5-10% of the CFU-C 
in the bone marrow of BN recipients were of the LEW 
phenotype at 14, 30, and 60 days after transplantation. 
At 100 days, however, donor CFU-C could no longer be 
found at this site. The pattern of LEW CFU-C in the 
bone marrow of BN liver recipients up to 60 days was 
similar to that in recipients of 2.5 x 108 BMC, although 
the donor colonies were only 1120 to 11200 as numer-
ous. This was expected, because the progenitor cells in 
the passenger leukocytes of a single liver are equiva-
lent to those in 1-5x106 BMC. Using a liquid CFU-C 
assay, donor progenitor cells were demonstrated 
among the nonparenchymal cells of liver allografts up 
to 100 days. In contrast, after heart transplantation, 
donor CFU-C could not be identified in the recipient 
bone marrow, even at 14 days. 
Conclusion. Under effective immunosuppression, al-
logeneic hematopoietic progenitors compete effec-
tively with host cells for initial engraftment in the 
bone marrow of noncytoablated recipients, but disap-
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pear from this location between 60 and 100 days after 
transplantation, coincident with the shift of donor leu-
kocyte chimerism from the lymphoid to the nonlym-
phoid compartment that we previously have observed 
in this model. It is possible that the syngeneic paren-
chymal environment of the liver allografts constitutes 
a privileged site for persistent progenitor donor cells. 
The axiom that pluripotent hematolymphopoietic stem 
cells are confined to the bone marrow of mature animals and 
humans (1) has been challenged by evidence that pluripotent 
progenitor cells also reside in organs. It has been demon-
strated that all hematopoietic lineages can be fully reconsti-
tuted by the transplantation of syngeneic livers or hearts to 
supralethally irradiated rodents (2, 3) or by infusing small 
numbers of allogeneic CD34 + stem cells purified from allo-
geneic livers (4). It was not clear from such experiments, 
however, where in the recipient these migratory stem cells of 
bone marrow origin take up residence, and specifically 
whether the transplanted organs themselves provide a par-
ticularly advantageous microenvironment for donor stem cell 
nesting and maintenance, We have examined this question 
by transplanting Lewis (LEW*) strain rat, liver, heart, and 
bone marrow cells (BMC) to transiently immunosuppressed 
Brown Norway (BN) recipients. 
MATERIALS AND METHODS 
Animals and surgical procedures. Male LEW (RT11) and BN 
(RTP) rats weighing 200-300 g (10-12 weeks old) were purchased 
from Harlan Sprague Dawley, Inc. (Indianapolis, IN) and main-
tained in a laminar-flow, specific pathogen-free atmosphere at the 
University of Pittsburgh. Heart and liver whole organ allografts, as 
well as BMC, were harvested from LEW donors. Orthotopic liver and 
heterotopic (intra-abdominal) heart transplantation was performed 
with previously described procedures (5, 6). 
The LEW BMC were taken from the tibias and femurs, and 
processed in RPM! 1640 supplemented with 25 mM HEPES, 2 mM 
L-glutamine, and 50 lLg/ml gentamicin (all from Life Technologies, 
Grand Island, NYl. Trypan blue exclusion testing uniformly showed 
>95% viability ofBMC. The LEW BMC (2.5x10B) were injected into 
the penile vein of BN recipients. Based on the ability to reconstitute 
supralethally irradiated syngeneic rats, the number of pluripotent 
* Abbreviations: BMC, bone marrow cells; BN, Brown Norway; 
CFU-C, colony-forming unit(s) in culture; FBS, fetal bovine serum; 
GM-CSF, granulocyte-macrophage colony-stimulating factor; IMDM, 
Iscove's modified Dulbecco's medium; LEW, Lewis; mAb, monoclonal 
antibody; 2·ME, mercaptoethanol; NPC, nonparenchymal cells; TCR, T 
cell receptor; PBS, phosphate-buffered saline; NMA, ~-monomethyl· 
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progenitor cells in this dose ofleukocytes was estimated to be 20-200 
times greater than that in a single liver (2). 
All BN recipients were treated with tacrolimus (FK506) (Fujisawa 
Pharmaceutical Co. Ltd., Osaka, Japan), which was dissolved in 
HCO-60 and D mannitol and suspended in normal saline. Daily 
intramuscular doses of 1.0 mg/kg were given on days 0 to 13 followed 
by single doses on days 20 and 27. 
Donor cell phenotyping. As previously reported (6), LEW leuko-
cytes can be identified in BN recipients by immunohistochemical 
staining with the L21-6 monoclonal antibody (mAb), which recog-
nizes the MHC class II antigens of LEW, but not BN (7). The 
numbers and lineages of donor (LEW) hematolymphoid cells in the 
spleen and lymph nodes of these recipients 30 and 100 days after 
transplantation have been published elsewhere (6) and are summa-
rized as follows: 
Number of donor MHC 
Graft class II + cells' Lineages 
30 days 100 days 
Heart <5 Not tested 
Bone marrow 5< <10 <5 Multilineage 
Liver 10< <50 <5 T cell dominant 
Multilineage 
*mAb L21-6+ cells in a whole mounted section of the spleen and 
lymph nodes_ 
Cell preparation. The BN recipients of the different kinds of LEW 
allografts were killed after 14, 30, 60, and 100 days. Liver allografts, 
and recipient tibias and femurs, were removed and examined for the 
presence of LEW hematopoietic progenitor cells by in vitro colony-
forming unit in culture (CFU-C) assay and in vivo adoptive transfer 
into lethally irradiated recipients. 
BMC: A crude fraction ofBMC was obtained by flushing the tibial 
and femoral medulla with RPMI 1640 medium. After lysing the red 
blood cells by hypotonic solution, cells were re~uspended in RPMI 
1640, supplemented with 5% fetal bovine serum (FBS), 10 mM 
HEPES, 2 roM L-glutamine, 50 fLg/ml gentamicin, and 5X10-5 M 
2-mercaptoethanol (2-ME; Life Technologies). 
Aliquots of 15-20X 106 BMC were seeded into lO-cm culture dishes 
(Falcon. Lincoln Park, NJ). After an incubatiDn for 2 hr at 37°C, the 
plastic dish-nonadherent BMC were collected and resuspended in 
complete Iscove's modified Dulbecco's medium (lMDM; Sigma, St. 
Louis, MOl, supplemented with 10 mM HEPES. 8 roM L-glutamine, 
50 fLg/ml gentamicin, and 5x 10-5 M 2-ME. 
Liver nonparenchymal cells (NPC): Nylon wool-nonadher-
ent NPC were isolated from the liver by the collagenase 
digestion method of Berry and Friend (8) with some modifi-
cations. Briefly, the portal vein or the thoracic inferior vena 
cava was cannulated with a IS-gauge plastic catheter. The 
liver was perfused in situ at 30 mllmin initially with 120 ml 
of Hanks' balanced salt solution (Life Technologies), contain-
ing 5 mM EGTA (Sigma), 10 mM HEPES, and 50 J.Lglml 
gentamicin. then with 300 ml of Leibovitz's L-15 medium 
(Life Technologies) containing 0.05% collagenase (type B; 
Boehringer Mannheim. Mannheim. Germany), 0.005% tryp-
sin inhibitor (type H-S; Sigma), 2.5% FBS, 10 mM HEPES. 
and 50 f.Lg/ml gentamicin. After perfusion. the liver was re-
moved into a Petri dish. and NPC and parenchymal cells 
were liberated from the connective tissue by carefully raking 
the liver with scissors and shaking the liver gently. 
The initial cell suspension was filtrated through a nylon 
mesh. and a crude fraction ofNPC was separated from hepa-
tocytes by low-speed centrifugatlon dive urnes at 70 Xg for 4 
min) and washed by high-speed centrifugation (three times 
at 280xg for 8 min). The crude NPC suspension was subse-
quently overlaid on discontinuous Percoll density gradients 
and centrifugated at 750xg for 30 min. Purified NPC were 
obtained in an interface (1.051-1.084) by depleting debris, 
dead cells. contaminating hepatocytes, and red blood cells. 
The NPC suspension was then passed through a nylon wool 
column, and nylon wool-nonadherent NPC were finally ob-
tained in complete IMDM. 
CFU-C. Semisolid culture system: Our previously de-
scribed CFU-C assay was performed, using a fibrin clot cul-
ture system with some modification (3, 9, 10). Plastic dish-
nonadherent BMC and nylon wool-nonadherent hepatic NPC 
in complete IMDM were further mixed with 2% pokeweed 
mitogen (Sigmal-stimulated LEW spleen cell-conditioned 
medium, 20% FBS, 1% bovine serum albumin, 0.5 mM NG _ 
monomethyl-L-arginine-HOAc (NMA; Cycl03Pss Biochemical 
Co., Slake Lake, UT), 0.5 mg/ml bovine fibrinogen solution 
(Sigma), and 0.5 Dlml bovine thrombin solution (Sigma) in 
final concentrations of 0.5-5 x 105 and 1 x 106/ml, respec-
tively. A total suspension volume of 1.0 ml was plated in the 
middle of a SO-mm Parmanox dish (Nunc, Naperville, ILl. 
After clot formation. 1.0 ml of complete IMDM with 20% 
FBS and 1% bovine serum albumin was added around the 
clot. The culture was kept for 6 days in a fully humidified 
atmosphere with 5% CO2 in air at 37°C. On day 6, the outer 
medium layer around the clot was discarded, and the clot was 
slowly dried in the incubator for 5 hr. The flattened clot was 
then fixed either with absolute methanol for 30 min and 
washed with H 20 for Giemsa staining (Sigma), or fixed with 
95% ethanol for 1 hr, air dried for another 1 hr, and washed 
with phosphate-buffered saline (PBS) for immunohistochem-
ical staining. Clusters (10-50 cells/aggregate) and colonies 
(>50 cells/aggregate) were counted as CFU-C counts. 
Liquid culture system: The assay previously described by 
Lu et al. (Ii) for the propagation of dendritic cells was per-
formed with modifications, in parallel with the semisolid 
method to identify progenitor cells. Although the method of 
Lu et a1. (J 1) was used, the cell population analyzed was 
different. In the original investigation of Lu et a1. (J 1), the 
dendritic-shaped cells released from the clusters and floating 
in the medium were stained. In the present study, floating 
cells were removed from the cul~ure and only adherent colo-
nies were stained. Briefly, 2 X 106 liver NPC from the crude 
fraction or un fractional BMC were placed in a 24-well plate 
(Corning Inc., Corning, NY) in 2 ml of RPM! 1640, supple-
mented with 10% FBS, 2 mM L-glutamine, 0.1 mM nones-
sential amino acids. 1 mM sodium pyruvate, 50 lLg/ml gen-
tamicin, 2x 10-5 M 2-ME. 0.5 mM NMA. and 0.4 ng/ml 
recombinant murine granulocyte-macrophage colony-stimu-
lating factor (GM-CSF; R&D Systems Inc., Minneapolis, 
MN)' The cultures were fed every other day with a fresh 
recombinant murine GM-CSF-supplemented medium after 
gently swirling the supernatant and discarding 50% of the 
medium in each well. Twenty-four hours before terminating 
the cultures. recombinant rat interferon-y (100 D/ml; Gen-
zyme. Cambridge, MA) was added to increase MHC class II 
expression of cultured cells. 
Propagated cells in this system showed morphologic fea-
tures of dendritic cells and macrophages. After culturing for 
more than 10 days. the number of propagated colonies in this 
,;ystem. 111 which naating cells were simultaneously gener-
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FIGURE L L21-6-positive CFU-C in normal 
BMC. Plastic dish-nonadherent LEW or BN 
BMC (SX 104 ) were cultured in a fibrin clot 
culture system for 6 days and generated 
CFU-C that were exposed to mAb L21-6. (Al 
CFU-C in BN BMC were not stained with 
L21-6. (B) The positively stained dispersed-
type CFU-C in LEW BMC were composed of 
macrophages and dendritic like cells (without 
counterstain) (Original magnification; x 100). 
'A' 8 .. , 
ated, was much greater than that in the semisolid fibrin clot 
culture system. After removing non adherent floating cells by 
gently aspirating the supernatants, loosely or firmly adhered 
colonies in wells were air dried for 2 hr, fixed with 95% 
ethanol for 1 hr, and air dried for another 1 hr for immuno-
histochemical staining. 
Phenotvpmg of cultured cells. The CFU-C derived from LEW (do-
nor) hematopoietic stem cells were identified by in situ immuno-
chemical staining with mAb L21-6 of propagated colonies in the 
fibrin clot and liquid culture systems. using a standard three-step 
avidin-biotin complex method. Endogenous avidin-biotin activity 
and nonspecific bindings were blocked with avidin-biotin blocking kit 
(Vector. Burlingame. CAl and heat-inactivated normal BN serum 
(L10). respectively. After incubation with mAb L21-6 for 2 hr at 
room temperature, samples were washed with PBS. placed in meth-
anol containing 1'1 e~l~ for 10 min to deplete endogenous peroxi-
dase activity. washed in PBS for 20 min. and further incubated with 
normal rat serum (1: 10: Sigma) for 20 min. 
A biotinylated rat anti-mouse Fab., fragment (1:500: Jackson Im-
munoResearch. West Grove, PAl was used as a secondary antibodv 
• 
for 45 min. After washing with PBS, samples were incubated with 
avidin-biotin complex (Vector) for 30 min, and color development was 
achieved with aminoethylcarbozole (ScyTek, Longan, UT). Cells 
were counterstained with hematoxylin. CFU-C in the fibrin clot 
culture and colonies in the liquid culture were considered to be 
derivative from LEW hematopoietic stem cells only when they were 
composed of L21-6-positive cells. 
Established colonies were also analyzed for their surface lineage 
markers using the same in situ stain method as described above. 
mAb used were ED1 (macrophages, 1:100). ED2 (macrophages. 
1:10m. and R7.3 (all-T cell receptor (TCR!. 1:25-100) (all from Sero-
tee. Oxford. UK), All staining experiments were performed with 
controls including fibrin clot CFU-C and spleen sections obtained 
from normal LEW and BN rats. Nonimmune isotype antibody 
Imouse IgGll was also used for negative control in each assay. 
En vivo propagation of' donor hematopoietic progenitor cells in 
Idhallv irradiated recipients. The same BMC used for CFU-C assay 
were infused into lethally irradiated (9.5 Gy delivered from a cesium 
source) EN recipients (1.5 x 10M unfractionated BMC per animal). 
Between 40 and 60 davs atter bone marrow transplantation. the 
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FIGURE 2. The number ofL21-6-positive (LEW) CFU-C per 5x105 
cells in three mixtures of naive LEW and BN BMC. Culture and 
assay conditions as in Figure 1. Data indicate average :t: SD from 
three experiments. 
peripheral blood was taken and percentages of donor (LEW) cells 
were analyzed by flow cytometry using affinity-purified biotinylated 
mAbs 163 (rat IgG2b) and 42 (rat IgG2a), which are specific for the 
RTl.A2 (MHC class I) antigen on LEW and RTl.An antigen on BN, 
respectively (12). Subsequently, animals were challenged with LEW 
or ACI heart grafts to examine the development of LEW-specific 
graft acceptance. 
RESULTS 
CFU·C in normal untransplanted animals. In BMC: The 
BMC of normal LEW and BN rats had a similar frequency of 
hematopoietic progenitor cells, as judged by the CFU-C in the 
fibrin clot culture system. The total CFU-C counts per 5x104 
plastic dish-nonadherent BMC were 54=:18 (8m LEW (n=3) 
and 43=:4 BN (n=3). By morphologic criteria after Giemsa 
staining, the majority of colonies were composed of macro-
phage lineage and dendritic-like cells. In situ immunohisto-
chemical stain confirmed that the percentage of ED1 + and 
ED2+ cells (mature macrophages) were 60.9=:17.4% and 
40.9=:11.2% in LEW BMC (n=3) and 55.8=:17.1% and 
40.1=:5.2% in BN BMC (n=3), respectively. With conven-
tional cytoplasmic enzyme staining of the same samples, the 
majority of colonies were myeloid lineage (including weakly 
stained immature macrophages): 7.6=:2.1% in LEW BMC 
(n=3) and 6.5=:1.7% in BN BMC (n=3) were peroxidase-
positive granulocyte colonies, whereas 85.9% =: 2.1% in LEW 
(n=3) and 86.6=:1.9% in BN BMC (n=3) were nonspecific 
esterase-positive macrophage colonies. 
None of the CFU-C generated from BN BMC were stained 
with the mAb L21-6 (Fig. 1Al. Interestingly, only 39=:9% 
(Sm ofCFU-C generated from the LEW BMC were stained in 
situ with mAb L21-6. The dispersed type of LEW CFU-C 
generally were composed of iO1-S~ cells, whereas concen-
trated CFU-C tended to be L21-6-, suggesting that differ-
ences between L21-6-positive and -negative colonies de-
pended on the maturation stages of macrophage and 
dendritic cell development from hematopoietic progenitors 
(Fig. IB). 
To determine the sensitivity with which small numbers of 
LEW CFU-C could be detected, plastic dish-non adherent 
BMC from naive animals were mixed at various LEWIBN 
ratios from 1:10 to 1:1000 and subjected td CFU-C assay. 
When the LEW BMC constituted 0.1, 1.0, and 10% of the 
5 x 105 cells in the mixture, the numbers of L21-6-positive 
CFU-C were 0.2=:0.4, 2.3=:1.4, and 21.3:::5.7 (8m (Fig. 2). 
The majority of cells in the semisolid culture of LEW and 
BN BMC mixture were positive for ED1 (>80%) and ED2 
(>55%). There was no colony or individual cell stained with 
mAb specific for al3TCR <R7.3), showing that detectable 
growth of activated lymphocytes does not occur in this cul-
ture system even after mixing allogeneic BMC. For the con-
trol, activated T cells obtained from standard mixed lympho-
cyte culture were stained with R7.3, and positive stain was 
confirmed. 
In liver NPC: Using 106 nylon wool-nonadherent NPC ob-
tained from naive LEW liver (rather than the 5x 104 plastic 
dish-nonadherent cells used for the bone marrow studies), 
7.9=:3.9 CFU-C were generated (n=3). Similar to those ob-
tained from BMC in the same culture system, the majority of 
colony. forming cells were macrophages and/or dendritic-like 
cells; 35=:6% (8m of the CFU-C stained with L21-6 com-
pared with the 39=:9% in comparably prepared LEW BMC 
(see above). 
CFU-C in bone marrow recipients. After infusion of 
2.5X 108 LEW BMC into BN recipients, LEW CFU-C were 
easily identified with the mAb L21-6 stain in the plastic 
dish-nonadherent recipient BMC (Fig. 3A). Mean donor 
CFU-C at 14, 30, and 60 days after transplantation were 5.4, 
25.9, and 7.8, respectively (Table 1). Based on the results 
obtained from in vitro mixing of normal LEW and BN BMC 
(Fig. 2), the percentage of donor contribution to the total 
hematopoietic progenitor cell population in the recipient 
bone marrow was estimated to be 5-10% during the first 2 
months after transplantation. By 100 days, however, donor 
CFU-C were no longer detectable with this assay. 
CFU-C in liver recipients. In bone marrow: At 14 (n=4) 
and 30 days (n=2) after transplanta.tion, all six recipient 
animals had donor CFU-C in their bone marrow: 1.0 and 0.3, 
respectively, at the two time periods (Table 1). The percent-
age contribution to the total hematopoietic progenitor cell 
population in recipient bone marrow was estimated to be 
0.1-0.5%. This was only 1/10 to 1/100 that at comparable 
times after bone marrow infusion. This finding was consis-
tent with the smaller number of progenitor cells thought to 
be contained in one liver compared with that in 2.5 X lOll 
BMC. No donor L21-6+ colonies were found in later bone 
marrow samples with the semisolid culture system. 
In the liver allografts: The invariable presence of multilin-
eage microchimerism at 100 days in the LEW ..... BN liver 
transplantation model (6) as well as the persistence of a 
small population of donor leukocytes in the hepatic graft (13) 
caused us to suspect that the transplanted liver might be a 
nesting site for donor progenitor cells. However. when the 
nylon wool-nonadherent NPC from the grafted liver were 
cultured in the fibrin clot system. total CFU-C counts were 
too small even at 30 days after transplantation (6.1=:2.8 per 
10° cells: n = 2) to study the frequency of L21-6 - colonies. 
The possibility could not be ruled alit. however. that the low 
progenitor cell yield was due in part to differences in the 
preliminary steps of cell separation l i.e .. more traumatic for 
liver NPC than for BMC). 
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FIGURE 3. (A) L21-6-positive donor (LEW) CFU-C in BN recipient bone marrow after LEW bone marrow infusion. CFU-C in BN recipient 
BMC obtained 30 days after LEW bone marrow infusion and studied with the same assay as in Figure 1. Three individual L21-6-positive 
(LEW) CFU-C are identified in this field (Original magnification; X40). Colonies developed from liver NPC (30 days after transplantation) 
in a liquid culture system were mostly (B) ED2-positive and (C) a{3TCR-negative. L21-6-positive donor colony in liver NPC (D) 30 days and 
(E) 100 days after transplantation into BN recipient. A crude fraction of NPC was obtained from liver allografts and cultured in a liquid 
culture system with recombinant murine GM-CSF. After 18 days of culturing, loosely or firmly adherent colonies in the wells were fixed and 
in situ stained with mAb. ED2, R7.3, and L21-6. A colony is shown that contains both weak and strong (L21-6) positive macrophage lineage 
and dendritic like ceJls (original magnification; B, x40; C, X40; D, x 200; E, x 100). (F) Singly identified donor phenotype cells in the liquid 
culture of BMC 100 days after liver transplantation (tacrolimus 1.5 rng/kglday on days 0-13. 20, 27; Original magnification; x 100 without 
counterstain), 
Therefore. the liquid culture system developed by Lu et a1. 
(] II was used. which allowed the generation of more colonies 
from the crude NPC preparation; in addition, the doses of 
tacrolimus were increased to 1.5 mg/kg. After culturing these 
cells for 14 to 28 days, the propagated cells, which resembled 
macrophages and dendritic cells, were shown to be 
97.8:!:1.0% (n=3) ED2 strong positive (Fig. 38) and 
84.l:!:2.6% (n=3) EDl weak positive. We were not able to 
detect any colony or individual cell stained with mAb specific 
for al3TCR (Fig. 3C), confirming earlier observations by Lu et 
a1. (Ill using this long-term liquid culture enriched with 
GM-CSF. 
The donor phenotype colonies were easily identified in the 
cultures of NPC obtained from grafted livers 30 days after 
transplantation (n=3); the L2l-6+ colonies were estimated 
to range fro'm 1 to 10% of all propagated colonies (Fig. 3Ol. 
Donor colonies also were seen in liver NPC 60 days after 
transplantation (n =:2). but at a < 1 % incidence. At 100 days 
838 TRANSPLANTATION Vol. 67, No.6 
TABLE 1. Donor MHC class ff~ CFU-C in the bone marrow of BN 
recipients after liver, heart, or bone marrow transplantation 
Days after Donor MHC class Graft/cells n II+ CFU-C counts Mean transplantation (per 5x 105 BMC) 
Bone marrow 14 3 4.1, 5.3, 6.8 5.4 
30 2 21.5,30.2 25.9 
60 2 6.3,9.3 7.8 
100 4 0,0,0,0 0 
Liver 14 4 0.3, 0.6, 1.5, 1.5 1.0 
30 2 0.1,0.5 0.3 
60 2 0, ° 0 
100 2 0,0 0 
Heart 14 2 0,0 0 
Plastic dish-nonadherent BMC from BN recipients after LEW 
bone marrow (2.5X 108 ), liver, or heart transplantation were cultured 
in the fibrin clot culture system (5X 105 cells/plate, 10 plates/each 
experiment). After culturing for 6 days, established CFU-C were in 
situ stained with mAb L21-6 (LEW MHC class lI), and the number of 
CFU-C composed of strongly stained cells was counted. 
after liver transplantation, donor L21-6+ colonies were rare 
«0.1 %), but definitely existed among NPC obtained from the 
liver allograft (Fig. 3E). 
Donor phenotype cells, but not colonies, were simulta-
neously detected in the bone marrow of these recipients using 
both semisolid and liquid culture systems. Interestingly, do-
nor cells in the recipient bone marrow were mostly identified 
as an isolated single cell or aggregates of a few cells (Fig. 3F). 
These results suggested that some of the organ-based hema-
topoietic progenitor cells either persisted in, or else returned 
to, the grafted liver after transplantation. 
CFU-C in heart recipienJs. The recipient bone marrow did 
not have detectable levels ofCFU-C 14 days after heterotopic 
heart transplantation (Table 1). Samples were not obtained 
at later times. 
LEW heart graft survival in secondary 9.5-Gy irradiated 
BN recipients reconstituted with transferred BMC. Controls: 
LEW heart grafts were' rejected by naive BN anim~ls with a 
median survival of 10 days (n=7). When lethally irradiated 
BN animals were reconstituted with BMC obtained from 
naive or tacrolimus-treated BN animals (without a LEW 
graft), LEW heart grafts were rejected within 16 days (group 
1-4, Table 2). There was no significant difference in heart 
graft survivals. whether the BMC for reconstitution were 
obtained at 14 (group 2), 60 (group 3), or 100 days (group 4) 
after the initiation of tacrolimus treatment. 
Adoptive transfer: When BMC were obtained 30 and 60 
days after LEW bone marrow infusion. reconstituted animals 
accepted LEW heart grafts for 100 days without any immu-
nosuppressive treatment (group 5 and 6). Flow cytometric 
analysis of the peripheral blood obtained from these animals 
before heart grafting revealed that 1.0 to 6.0% were LEW 
phenotype cells. In these animals. third-party ACI hearts 
were normally rejected in 7 days (n=3l. 
The adoptive transfer effect was not detectable in BN an-
imals reconstituted with the BMC obtained from BN animals 
100 davs after LEW bone marrow infusion (group 7); LEW 
heart Iiraft survival was reduced to 12 days. When lethally 
irradiated BN rats were reconstituted with BMC from BN 
animals that had been carrying LEW liver grafts for 14 
(group 8), 30 (group 9), 60 (group 10), and 100 (group 11) 
days, animals rejected LEW heart grafts with median sur-
vivals between 7 and 13 days. Transfer of BMC obtained 30 
days after LEW to BN heart transplantation had no effect on 
LEW heart graft survival (group 12). 
DISCUSSION 
It is well known that migratory organ "passenger leuko-
cytes" of bone marrow origin, like infused BMC, home selec-
tively at first to organized lymphoid collections (13-17). Our 
specific purpose here was to obtain information about the 
destination of the subset of progenitor cells without which 
long-term perpetuation of posttransplantation chimerism 
would not be possible (18, 19). It was possible to make a 
precise distinction between donor and recipient hematopoi-
etic cells with the mAb L21-6 that stains MHC class II+ cells 
of LEW, but not of BN rats (7). This phenotyping tool in 
combination with the CFU-C technology made the search for 
progenitor cells feasible. 
Because only 35-40% of the LEW colonies stained with the 
mAb L21-6, the number of donor CFU-C was considerably 
underestimated. Nevertheless, our experiments demon-
strated the movement of donor progenitor cells into the re-
cipient bone marrow. Although it has been a common as-
sumption that recipient cytoablation is necessary to "create 
space" or "open niches" for infused leukocytes, many studies 
have suggested that syngeneic marrow cells can compete 
equally with host hematopoietic cells for long-term residence 
with an engraftment rate near theoretical maximum (20-23). 
A recent study by Ehl et a1. (24) has shown the same thing in 
untreated mice despite a class I-restricted minor histocom-
patibility barrier. 
The present study showing a 5-10% proportion of donor 
progenitor cells after infusion of 2.5 x 108 fully allogeneic 
BMC demonstrated the same thing, early after their infu-
sion. The subsequent decline of these cells in our noncytoa-
blated recipients occurred only after the cessation of immune 
suppression. Thus. it can be suggested that the effectiveness 
of cytoablation in the promotion of persistent allogeneic cell 
engraftment is more related to its weakening of the host 
immune response than to the provision of space. 
With the LEW-BN strain combination used in our experi-
ments, long-term organ engraftment is routine despite the 
variable development of low-grade chronic rejection (6). In 
this model. Terakura et a1. (5) have demonstrated the previ-
ously unrecognized secondary migration LEW leukocytes of 
heart allografts and of BMC from BN recipient lymphoid 
organs and blood to nonlymphoid sites (e.g., skin and native 
heart) between 56 and 100 days after transplantation. Thus. 
it is conceivable that donor progenitor cells may be found in 
unexpected nonlymphoid locations. 
One of the candidate sites for survival of allogeneic pro-
genitor cells consistent with observations in the present 
study, is the microenvironment of the transplanted organ. 
which is syngenic to the surviving donor leukocytes. In a 
well-tolerated organ allograft. most of the departed passen-
ger leukocytes are replaced by functionally nonreactive host 
cells of the same lineages \lB. 25-27), a change that is nearly 
complete within 14 days in the rat (26l. However. an esti-
mated 5% of the leukocytes in an "accepted" organ allograft 
remain of donor phenotype t131. It is not known whether this 
reSIdual population has failed to migrate or whether it is the 
consequence of recirculation. Despite technical difficulties, 
'f 
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TABLE 2. LEW heart graft survival in secondary 9.5-Gy irradiated BN recipients reconstituted with transferred BMC 
Group 
1 
2 
3 
4 
5b 
6b 
7 
8 
9 
10 
11 
12 
Bone marrow donor 
Original LEW 
grafticells 
None 
Bone marrow 
Liver 
Heart 
Days after original 
transplantation 
NAc 
14 
60 
100 
30 
60 
100 
14 
30 
60 
100 
30 
n LEW heart graft survivala (days) Median (days) 
3 8, 8, 13 8.0 
5 11, 11, 12, 12, 12 12.0 
4 8,11,11,11 11.0 
10 9, 11, 11, 11, 12, 13, 13, 13, 16, 16 12.5 
5 >100X5 >100 
10 10, >100x9 >100 
10 8, 10, 11, 11, 11, 13, 13, 14, 14, 15 12.0 
5 6,6,7,7,8 7.0 
4 6,7,8,8 7.5 
5 9, 10, 11, 12, 13 11.0 
8 1~ 1L 11, 13, 13, 1~ 14, 15 13.0 
5 10, 12, 13, 13, 13 13.0 
a LEW heart graft survival in naive BN recipients was 8, 8, 9, 10, 10, 11, and 11 days. 
b Third-party (ACn heart graft survival in these animals was 7 days (n=3). 
C NA, not applicable. 
some of these donor leukocytes within the liver grafts were 
shown in the present study to be progenitor cells. 
It remains to be determined whether an organ allograft, 
syngeneic to its peripheralized passenger leukocytes, pro-
vides an especially advantageous microenvironment for the 
nesting of donor stem cells. If so, this would be consistent 
with evidence (summarized in 6 and 28) that microchimerism 
is easier to maintain in a recipient who also has an organ. 
Such chimerism or even macrochimerism often is lost in 
controlled experimental models when the organ allograft is 
removed. 
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BONE MARROW CHANGES IN HEART TRANSPLANT RECIPIENTS 
WITH PERIPHERAL CYTOPENIA 1 
ALESSANDRO CASTELLO,2 BARBARA DAL BELLO,2 CATHERINE KLERSy,3 ANGELA PrSTORIO,3 
MARIo VIGANO,4 GIAMBATTISTA IpPOLITI,5 AND ELOISA ARBuSTINr2,6 
Departments of Pathology, Cardiac Surgery, and Internal Medicine, and Biometric Unit, 
IRCCS-Policlinico San Ma(teo-University of Pavia, 27100 Pavia, Italy 
Background. We analyzed bone marrow changes in 
heart transplant recipients who develop peripheral 
cytopenia and underwent bone marrow biopsy (BMB). 
We correlated the changes in bone marrow with sur-
vival, acute and chronic rejection, infections, and ma-
lignancy. 
Methods. The test group was constituted of 64 heart 
transplant recipients with peripheral cytopenia, in 
whom 82 BMBs were performed to assess marrow 
. quantitative (cellularity, erythropoiesis, myelopoiesis, 
megakaryopoiesis, fibrosis, and blast cells) and quali-
tative (dyserythropoiesis, dysmyelopoiesis, and dys-
megakaryopoiesis) changes. The control series was 
constituted of 217 matchable transplant recipients 
without cytopenia. Statistical analysis was aimed at 
assessing whether: (1) cytopenia is an independent 
risk factor for survival; (2) acute rejection, chronic 
rejection, infections, and malignancy predict cytope-
nia; (3) the degree in BMB change allows further strat-
ification of the risk of death; and (4) characteristics 
and distribution of BMB lesions vary in patients with 
1 This work was supported by grant "Ricerche Finalizzate" Health 
Ministry to Policlinico San Matteo, Pavia. 
Z Pathology Department. 
3 Biometric Unit. 
4 Cardiac Surgery Department. 
5 Internal Medicine Department. 
6 Address correspondence to: Dr. Eloisa Arbustini. Istituto di 
Anatomia Patologica. Viale Forlanini 16. 27100 Pavia. ltalv. E·mail: 
earbustini@Smatteo.pv.it. 
and without acute and chronic rejection, infections, 
and malignancy. 
Results. In the test group, BMB specimens showed 
reduced cellularity in 68% of patients and dysplastic 
changes of a mild degree affecting all three marrow 
lines (erythropoietic in 88%, myelopoietic in 43%, and 
megakaryopoietic in 79%). At statistical analysis, pe-
ripheral cytopenia was an independent risk factor for 
survival, and malignancy proved to be a risk factor for 
cytopenia. -Of BMB specimen changes, only dys-
megakaryopoiesis showed a trend as a negative risk 
factor for survival. Acute rejection was associated 
with a high score of erythropoiesis, infections with a 
low score of dysmegakaryopoiesis, and malignancy 
with a high score of cellularity. 
Conclusions. Peripheral cytopenia is an indepen-
dent risk factor for survival in heart transplant recip-
ients. Different marrow changes correlate with trans-
plantation-related complications, i.e., acute rejection, 
infection, and malignancy. 
Peripheral cytopenia may complicate the post-heart trans-
plantation course and may be accompanied by abnormalities 
of hemopoietic function (1). Bone marrow biopsy (BMB*) is 
the routine tool for investigating hemopoietic precursor 
changes (2) and is especially useful for staging of lymphopro-
liferative disorders and diagnosing hematologic malignancies 
(3, 4), for infection-related changes (5, 6), and in patients 
• Abbreviations: ALIP, abnonnallocalization of immature precur· 
sors: BMB. bone marrow biopsy. 
